Tumeurs du bassin : Questions médicales fréquentes
Nom anglais: Pelvic Neoplasms
Descriptor UI:D010386
Tree Number:C04.588.699
Termes MeSH sélectionnés :
Bone Neoplasms
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Tumeurs du bassin : Questions médicales les plus fréquentes",
"headline": "Tumeurs du bassin : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Tumeurs du bassin : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-05",
"dateModified": "2024-12-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Tumeurs du bassin"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Tumeurs par siège",
"url": "https://recherchemedicale.com/mesh/D009371",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs par siège",
"code": {
"@type": "MedicalCode",
"code": "D009371",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.588"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs du bassin",
"alternateName": "Pelvic Neoplasms",
"code": {
"@type": "MedicalCode",
"code": "D010386",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Naseema Gangat",
"url": "https://recherchemedicale.com/author/Naseema%20Gangat",
"affiliation": {
"@type": "Organization",
"name": "Mayo Clinic, Rochester, MN, USA."
}
},
{
"@type": "Person",
"name": "Kilian G M Brown",
"url": "https://recherchemedicale.com/author/Kilian%20G%20M%20Brown",
"affiliation": {
"@type": "Organization",
"name": "Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, Australia; Surgical Outcomes Research Centre (SOuRCe), Royal Prince Alfred Hospital, Sydney, Australia; Institute of Academic Surgery (IAS), Royal Prince Alfred Hospital, Sydney, Australia; Faculty of Medicine and Health, Central Clinical School, The University of Sydney, New South Wales, Australia."
}
},
{
"@type": "Person",
"name": "Umberto Gianelli",
"url": "https://recherchemedicale.com/author/Umberto%20Gianelli",
"affiliation": {
"@type": "Organization",
"name": "University of Milan, Department of Health Sciences and S.C. Anatomia Patologica, ASST Santi Paolo e Carlo, Milan, Italy."
}
},
{
"@type": "Person",
"name": "Jürgen Thiele",
"url": "https://recherchemedicale.com/author/J%C3%BCrgen%20Thiele",
"affiliation": {
"@type": "Organization",
"name": "Institute of Pathology, University of Cologne, Cologne, Germany."
}
},
{
"@type": "Person",
"name": "Attilio Orazi",
"url": "https://recherchemedicale.com/author/Attilio%20Orazi",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology, Texas Tech University Health Sciences Center, El Paso, TX, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Detection of Bone Metastases by",
"datePublished": "2022-11-07",
"url": "https://recherchemedicale.com/article/36447752",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/1750132"
}
},
{
"@type": "ScholarlyArticle",
"name": "Treatment of Bone Metastasis.",
"datePublished": "2022-07-22",
"url": "https://recherchemedicale.com/article/35892980",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/curroncol29080411"
}
},
{
"@type": "ScholarlyArticle",
"name": "Research progress of bone-targeted drug delivery system on metastatic bone tumors.",
"datePublished": "2022-08-27",
"url": "https://recherchemedicale.com/article/36007681",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jconrel.2022.08.034"
}
},
{
"@type": "ScholarlyArticle",
"name": "Predicting the Prognosis of Prostate Cancer Bone Metastasis Using the Bone Scan Index and Hot Spots Calculated Using VSBONEⓇ Bone Scan Index from Tc-99m-Hydroxymethylene Diphosphonate Bone Scintigraphy.",
"datePublished": "2022-03-04",
"url": "https://recherchemedicale.com/article/35249033",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000522046"
}
},
{
"@type": "ScholarlyArticle",
"name": "Update of pediatric bone tumors-notochordal tumors, chondrogenic tumors, and vascular tumors of the bone.",
"datePublished": "2022-11-11",
"url": "https://recherchemedicale.com/article/36369290",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00256-022-04235-x"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Recherchemedicale.com",
"item": "https://recherchemedicale.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Tumeurs",
"item": "https://recherchemedicale.com/mesh/D009369"
},
{
"@type": "ListItem",
"position": 3,
"name": "Tumeurs par siège",
"item": "https://recherchemedicale.com/mesh/D009371"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tumeurs du bassin",
"item": "https://recherchemedicale.com/mesh/D010386"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Tumeurs du bassin - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Tumeurs du bassin",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-02-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Tumeurs du bassin",
"description": "Comment diagnostique-t-on une tumeur du bassin ?\nQuels tests sont utilisés pour évaluer une tumeur pelvienne ?\nLes marqueurs tumoraux sont-ils utiles ?\nQuand faut-il consulter un médecin pour des symptômes pelviens ?\nLes examens d'imagerie sont-ils douloureux ?",
"url": "https://recherchemedicale.com/mesh/D010386?mesh_terms=Bone+Neoplasms&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Tumeurs du bassin",
"description": "Quels sont les symptômes courants des tumeurs pelviennes ?\nLes tumeurs pelviennes causent-elles des problèmes digestifs ?\nPeut-on avoir des symptômes sans tumeur visible ?\nLes tumeurs pelviennes provoquent-elles des douleurs pendant les rapports ?\nLes symptômes varient-ils selon le type de tumeur ?",
"url": "https://recherchemedicale.com/mesh/D010386?mesh_terms=Bone+Neoplasms&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Tumeurs du bassin",
"description": "Peut-on prévenir les tumeurs pelviennes ?\nLe tabagisme augmente-t-il le risque de tumeurs pelviennes ?\nL'alimentation joue-t-elle un rôle dans la prévention ?\nLes dépistages réguliers sont-ils importants ?\nL'exercice physique aide-t-il à prévenir les tumeurs ?",
"url": "https://recherchemedicale.com/mesh/D010386?mesh_terms=Bone+Neoplasms&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Tumeurs du bassin",
"description": "Quels traitements sont disponibles pour les tumeurs pelviennes ?\nLa chirurgie est-elle toujours nécessaire ?\nQuels sont les effets secondaires de la chimiothérapie ?\nLa radiothérapie est-elle efficace pour toutes les tumeurs ?\nPeut-on combiner plusieurs traitements ?",
"url": "https://recherchemedicale.com/mesh/D010386?mesh_terms=Bone+Neoplasms&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Tumeurs du bassin",
"description": "Quelles complications peuvent survenir avec les tumeurs pelviennes ?\nLes tumeurs pelviennes peuvent-elles affecter la fertilité ?\nY a-t-il des risques de récidive après traitement ?\nLes douleurs chroniques sont-elles une complication fréquente ?\nLes tumeurs pelviennes peuvent-elles causer des problèmes urinaires ?",
"url": "https://recherchemedicale.com/mesh/D010386?mesh_terms=Bone+Neoplasms&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Tumeurs du bassin",
"description": "Quels sont les principaux facteurs de risque des tumeurs pelviennes ?\nLes infections peuvent-elles augmenter le risque ?\nLe surpoids est-il un facteur de risque ?\nLes antécédents de cancer augmentent-ils le risque ?\nLe manque d'activité physique est-il un risque ?",
"url": "https://recherchemedicale.com/mesh/D010386?mesh_terms=Bone+Neoplasms&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une tumeur du bassin ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par imagerie (IRM, scanner) et biopsie."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer une tumeur pelvienne ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins, des échographies et des examens d'imagerie sont utilisés."
}
},
{
"@type": "Question",
"name": "Les marqueurs tumoraux sont-ils utiles ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains marqueurs peuvent aider à évaluer la présence de tumeurs."
}
},
{
"@type": "Question",
"name": "Quand faut-il consulter un médecin pour des symptômes pelviens ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez si vous avez des douleurs persistantes ou des changements urinaires."
}
},
{
"@type": "Question",
"name": "Les examens d'imagerie sont-ils douloureux ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La plupart des examens d'imagerie ne sont pas douloureux, mais peuvent être inconfortables."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des tumeurs pelviennes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleurs pelviennes, saignements anormaux et troubles urinaires."
}
},
{
"@type": "Question",
"name": "Les tumeurs pelviennes causent-elles des problèmes digestifs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent provoquer des douleurs abdominales et des troubles digestifs."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans tumeur visible ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains symptômes peuvent être présents sans tumeur détectable."
}
},
{
"@type": "Question",
"name": "Les tumeurs pelviennes provoquent-elles des douleurs pendant les rapports ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent causer des douleurs pendant les rapports sexuels."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de tumeur ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon le type et la localisation de la tumeur."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les tumeurs pelviennes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines mesures de prévention incluent un mode de vie sain et des dépistages réguliers."
}
},
{
"@type": "Question",
"name": "Le tabagisme augmente-t-il le risque de tumeurs pelviennes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est un facteur de risque pour plusieurs types de cancers."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut réduire le risque de développer des tumeurs."
}
},
{
"@type": "Question",
"name": "Les dépistages réguliers sont-ils importants ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils permettent de détecter les tumeurs à un stade précoce."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il à prévenir les tumeurs ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut réduire le risque de certains cancers."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les tumeurs pelviennes ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chirurgie, la radiothérapie et la chimiothérapie."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle toujours nécessaire ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la chirurgie dépend de la taille et du type de tumeur."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires de la chimiothérapie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure nausées, fatigue et perte de cheveux."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle efficace pour toutes les tumeurs ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, son efficacité dépend du type de tumeur et de son stade."
}
},
{
"@type": "Question",
"name": "Peut-on combiner plusieurs traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une approche multimodale est souvent utilisée pour optimiser les résultats."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les tumeurs pelviennes ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la propagation de la tumeur et des problèmes fonctionnels."
}
},
{
"@type": "Question",
"name": "Les tumeurs pelviennes peuvent-elles affecter la fertilité ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent compromettre la fertilité en affectant les organes reproducteurs."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de récidive après traitement ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de récidive dépend du type de tumeur et du traitement reçu."
}
},
{
"@type": "Question",
"name": "Les douleurs chroniques sont-elles une complication fréquente ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs chroniques peuvent persister après le traitement."
}
},
{
"@type": "Question",
"name": "Les tumeurs pelviennes peuvent-elles causer des problèmes urinaires ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent entraîner des difficultés urinaires et des infections."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque des tumeurs pelviennes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, les antécédents familiaux et le mode de vie."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles augmenter le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections, comme le HPV, sont liées à un risque accru."
}
},
{
"@type": "Question",
"name": "Le surpoids est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'obésité est associée à un risque accru de plusieurs cancers pelviens."
}
},
{
"@type": "Question",
"name": "Les antécédents de cancer augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir des antécédents de cancer augmente le risque de tumeurs pelviennes."
}
},
{
"@type": "Question",
"name": "Le manque d'activité physique est-il un risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire peut contribuer à un risque accru de cancer."
}
}
]
}
]
}
This study aimed to assess the efficacy of dual-tracer [...
We retrospectively enrolled 74 GEP-NEN patients with BMs from two centers, who underwent dual-tracer PET/CT from January 2014 to March 2021. We compared and analyzed effectiveness of the dual PET/CT i...
The detection efficiencies of dual-tracer PET/CT imaging in patients with different pathologies showed discordant for detecting liver metastases and BMs in group neuroendocrine tumor (NET) G3,...
Bone metastases are common in malignant tumors and the effect of conventional treatment is limited. How to effectively inhibit tumor bone metastasis and deliver the drug to the bone has become an urge...
The bone scan index (BSI) is widely used as a quantitative indicator of bone metastasis, therapeutic effect assessment, and prognosis prediction in prostate cancer. However, the BONE NAVI, which calcu...
We analyzed 322 patients who underwent bone scintigraphy for prostate cancer bone metastasis at our hospital. Initial bone scintigraphy was performed using Tc-99m-HMDP. All cases were retrospectively ...
When the patients were divided into two groups, HS >2 and HS ≤2, the HS ≤2 group had a significantly longer survival time (p < 0.001). In addition, when divided into two groups, BSI >0.46 and BSI ≤0.4...
BSI and HS obtained using VSBONEⓇ BSI may be useful as prognostic predictors, similar to those obtained using BONE NAVI....
There are numerous bone tumors in the pediatric population, with imaging playing an essential role in diagnosis and management. Our understanding of certain bone tumors has rapidly evolved over the pa...
Triptolide (TP) is known for its diverse pharmacological activities but also its delivery and toxicity issues. This study aimed at exploiting TP's anticancer effects at lower risk of systemic toxicity...
Bone metastases are common in advanced breast cancer (BC) patients and increase the risk for skeletal-related events (SREs), which present a significant health and economic burden. Bone targeting agen...
Metastatic bone disease (MBD) is the most common form of metastases, most frequently deriving from prostate cancer. MBD is screened with bone scintigraphy (BS), which have high sensitivity but low spe...
We collected 2365 BS from three European medical centres. The model was trained and validated on 1203 and 164 BS scans respectively. Furthermore we evaluated its performance on an external testing set...
The developed DL based algorithm is able to detect MBD on BSs, with high specificity and sensitivity (0.80 and 0.82 respectively on the external test set), in a shorter time compared to the nuclear me...
To determine whether computed tomography (CT) texture analysis parameters can be used as quantitative biomarkers to help differentiate giant cell tumour of bones (GCTs), primary aneurysmal bone cysts ...
One hundred and seven patients with 63 GCTs, 31 PABCs, and 13 GABCs were analysed retrospectively. All patients underwent preoperative CT. Two radiologists independently evaluated the qualitative feat...
The best preoperative CT parameters to differentiate GCTs, PABCs, and GABCs included one qualitative feature (location around the knee) and four texture parameters (95...
CT texture analysis parameters can be used as quantitative biomarkers for preoperative differentiation among GCTs, PABCs, and GABCs....
The reconstruction of extensive bone defects following resection of malignant bone tumours is a challenge and is mainly influenced by tumour-related factors. In defect reconstructions using distractio...